Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Dr Agarwal's Healthcare Eyes 20% Growth Amidst Aggressive Expansion and Merger Synergies

Healthcare/Biotech

|

Updated on 04 Nov 2025, 10:01 am

Whalesbook Logo

Reviewed By

Satyam Jha | Whalesbook News Team

Short Description :

Dr Agarwal's Healthcare is confident in achieving 20% revenue and profit growth this fiscal year, driven by rapid expansion plans and strong operational results. The company reported an 88% year-over-year jump in Q1 net profit to ₹75 crore. Brokerages are positive, citing merger benefits and network expansion. Jefferies projects 54 new facilities this fiscal, with a significant focus on South India and Delhi NCR, and has raised its target price to ₹480.
Dr Agarwal's Healthcare Eyes 20% Growth Amidst Aggressive Expansion and Merger Synergies

▶

Stocks Mentioned :

Dr Agarwal's Eye Hospital Ltd.

Detailed Coverage :

Dr Agarwal's Healthcare has expressed strong confidence in its outlook, projecting a 20% growth in both revenue and profit for the current fiscal year. This optimism is supported by robust first-quarter results, which saw net profit surge by 88% year-over-year to ₹75 crore, driven by efficient operations, ongoing facility additions, and effective cost management.

Brokerage firms remain constructive on the company. Motilal Oswal highlights the potential synergies from the ongoing amalgamation of Dr Agarwal's Eye Hospital with its parent, Dr Agarwal's Healthcare, along with growth in premium eye care services and network expansion.

In the second quarter of the fiscal year, while revenues met expectations, earnings surpassed estimates. EBITDA margins expanded to 27%, beating a 26% estimate, primarily due to reduced raw material and employee costs. Net profit for the September quarter stood at ₹30 crore, up from ₹16 crore a year ago, benefiting from improved operations, lower finance costs, and a reduced tax rate.

Jefferies anticipates significant physical expansion, expecting Dr Agarwal's Healthcare to add 54 new facilities this fiscal year, marking a 24% increase. A substantial portion of this expansion, 33 centers, is planned for South India. The company is also seeing a strong start in the Delhi market and plans to considerably scale its presence there within the next 12 months.

Management indicated that while EBITDA is expected to be slightly stronger in the second half of the year, margin percentages are likely to remain around 26% as the company continues its investment in greenfield expansions.

Impact: This news suggests significant growth potential for Dr Agarwal's Healthcare, driven by both organic expansion and potential merger benefits. This could lead to positive stock performance and increased investor interest in the eye care sector in India. Rating: 8/10

Difficult Terms: Fiscal Year: A 12-month period that companies use for accounting and financial reporting, which may not coincide with the calendar year (January-December). Year-over-year (YoY): A comparison of financial data over a period with the data from the same period in the previous year. Net Profit: The profit remaining after all expenses and taxes have been deducted from total revenue. EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure of a company's operating performance. EBITDA Margins: Calculated as EBITDA divided by revenue, expressed as a percentage. It indicates profitability from core operations. Basis Points (bps): A unit of measure equal to one-hundredth of a percent (0.01%). 100 basis points equal 1 percent. Scheme of Amalgamation: A legal process where two or more companies merge into one. Going Concern: A business that is assumed to continue operating indefinitely into the future. Greenfield Expansion: Establishing a new business or facility from scratch in a location where there was no previous business activity.

More from Healthcare/Biotech

Dr Agarwal’s Healthcare targets 20% growth amid strong Q2 and rapid expansion

Healthcare/Biotech

Dr Agarwal’s Healthcare targets 20% growth amid strong Q2 and rapid expansion

Glenmark Pharma US arm to launch injection to control excess acid production in body

Healthcare/Biotech

Glenmark Pharma US arm to launch injection to control excess acid production in body

IKS Health Q2 FY26: Why is it a good long-term compounder?

Healthcare/Biotech

IKS Health Q2 FY26: Why is it a good long-term compounder?

Sun Pharma Q2 Preview: Revenue seen up 7%, profit may dip 2% on margin pressure

Healthcare/Biotech

Sun Pharma Q2 Preview: Revenue seen up 7%, profit may dip 2% on margin pressure

CGHS beneficiary families eligible for Rs 10 lakh Ayushman Bharat healthcare coverage, but with THESE conditions

Healthcare/Biotech

CGHS beneficiary families eligible for Rs 10 lakh Ayushman Bharat healthcare coverage, but with THESE conditions

Metropolis Healthcare Q2 net profit rises 13% on TruHealth, specialty portfolio growth

Healthcare/Biotech

Metropolis Healthcare Q2 net profit rises 13% on TruHealth, specialty portfolio growth


Latest News

Stock Radar: RIL stock showing signs of bottoming out 2-month consolidation; what should investors do?

Energy

Stock Radar: RIL stock showing signs of bottoming out 2-month consolidation; what should investors do?

ED’s property attachment won’t affect business operations: Reliance Group

Banking/Finance

ED’s property attachment won’t affect business operations: Reliance Group

SBI joins L&T in signaling revival of private capex

Economy

SBI joins L&T in signaling revival of private capex

Berger Paints Q2 net falls 23.5% at ₹206.38 crore

Industrial Goods/Services

Berger Paints Q2 net falls 23.5% at ₹206.38 crore

Fambo eyes nationwide expansion after ₹21.55 crore Series A funding

Startups/VC

Fambo eyes nationwide expansion after ₹21.55 crore Series A funding

Best Nippon India fund: Rs 10,000 SIP turns into Rs 1.45 crore; lump sum investment grows 16 times since launch

Mutual Funds

Best Nippon India fund: Rs 10,000 SIP turns into Rs 1.45 crore; lump sum investment grows 16 times since launch


Tourism Sector

MakeMyTrip’s ‘Travel Ka Muhurat’ maps India’s expanding travel footprint

Tourism

MakeMyTrip’s ‘Travel Ka Muhurat’ maps India’s expanding travel footprint

Radisson targeting 500 hotels; 50,000 workforce in India by 2030: Global Chief Development Officer

Tourism

Radisson targeting 500 hotels; 50,000 workforce in India by 2030: Global Chief Development Officer


Chemicals Sector

Jubilant Agri Q2 net profit soars 71% YoY; Board clears demerger and ₹50 cr capacity expansion

Chemicals

Jubilant Agri Q2 net profit soars 71% YoY; Board clears demerger and ₹50 cr capacity expansion

More from Healthcare/Biotech

Dr Agarwal’s Healthcare targets 20% growth amid strong Q2 and rapid expansion

Dr Agarwal’s Healthcare targets 20% growth amid strong Q2 and rapid expansion

Glenmark Pharma US arm to launch injection to control excess acid production in body

Glenmark Pharma US arm to launch injection to control excess acid production in body

IKS Health Q2 FY26: Why is it a good long-term compounder?

IKS Health Q2 FY26: Why is it a good long-term compounder?

Sun Pharma Q2 Preview: Revenue seen up 7%, profit may dip 2% on margin pressure

Sun Pharma Q2 Preview: Revenue seen up 7%, profit may dip 2% on margin pressure

CGHS beneficiary families eligible for Rs 10 lakh Ayushman Bharat healthcare coverage, but with THESE conditions

CGHS beneficiary families eligible for Rs 10 lakh Ayushman Bharat healthcare coverage, but with THESE conditions

Metropolis Healthcare Q2 net profit rises 13% on TruHealth, specialty portfolio growth

Metropolis Healthcare Q2 net profit rises 13% on TruHealth, specialty portfolio growth


Latest News

Stock Radar: RIL stock showing signs of bottoming out 2-month consolidation; what should investors do?

Stock Radar: RIL stock showing signs of bottoming out 2-month consolidation; what should investors do?

ED’s property attachment won’t affect business operations: Reliance Group

ED’s property attachment won’t affect business operations: Reliance Group

SBI joins L&T in signaling revival of private capex

SBI joins L&T in signaling revival of private capex

Berger Paints Q2 net falls 23.5% at ₹206.38 crore

Berger Paints Q2 net falls 23.5% at ₹206.38 crore

Fambo eyes nationwide expansion after ₹21.55 crore Series A funding

Fambo eyes nationwide expansion after ₹21.55 crore Series A funding

Best Nippon India fund: Rs 10,000 SIP turns into Rs 1.45 crore; lump sum investment grows 16 times since launch

Best Nippon India fund: Rs 10,000 SIP turns into Rs 1.45 crore; lump sum investment grows 16 times since launch


Tourism Sector

MakeMyTrip’s ‘Travel Ka Muhurat’ maps India’s expanding travel footprint

MakeMyTrip’s ‘Travel Ka Muhurat’ maps India’s expanding travel footprint

Radisson targeting 500 hotels; 50,000 workforce in India by 2030: Global Chief Development Officer

Radisson targeting 500 hotels; 50,000 workforce in India by 2030: Global Chief Development Officer


Chemicals Sector

Jubilant Agri Q2 net profit soars 71% YoY; Board clears demerger and ₹50 cr capacity expansion

Jubilant Agri Q2 net profit soars 71% YoY; Board clears demerger and ₹50 cr capacity expansion